Lecture 3 - Cancer Potpurri Flashcards

1
Q

chemotherapy-induced nausea/vomiting is mediated by the emesis center in the _____

A

medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

_____ is a dopamine antagonist used to reduce vomiting that does not cross the BBB very well = less risk of _____ side effects

A

domperidone;

extrapyramidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what anti-histamine blocks dopamine receptors as well and is used to treat vomiting?

A

promethazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

_____ antagonizes 5HT3 receptors and also decreases _____ stimulation

A

ondansetron, vagal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what drug can cause GI perforation?

A

bevacizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the small molecule Tyrosine Kinase inhibitors lapatinib, sunitinib, and pazopanib all can cause ____ toxicity

A

liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

which cancer drug class classically causes more severe bone marrow suppression?

A

alkylating agents ie cyclophosphamide/busulfun

cell cycle NON SPECIFIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the order of hematologic toxicity, for RBCS, platelets, PMNs

A

neutropenia first –> thrombocytopenia (Esp nitrosureas) –> anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what can be used to treat/prevent neutropenia?

A

GM-CSF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

name 2 drugs that have a side effect of increased risk hemorrhage

A

bevacizumab
sorafenib/carfilzomib

also ponatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

____ can cause photosensitivy/severe sunburn

A

5-FU;

also MTX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

doxorubicin and dactinomycin are associated with _____ ____ reaction, when a drug causes an inflammatory rxn to a tissue previously exposed to radiotherapy

A

radiation recall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

tyrosine kinase inhibitors and EGFR antibodies both cause a ____ rash. this correlates with a _____ response rate and outcome

A

acneiform;

higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what drug can cause hemorrhagic cystitis?

what do you use to prevent it?

A

cyclophosphamide/isofosfamide;

MESNA and hydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

premedication is mandatory for all patients treated with _____ to prevent hypersensitivity reactions

A

taxols (paclitaxel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what 3 drugs are associated with severe extravasation reactions?

A

anthracyclines, nitrogen mustards, vinca alkaloids

17
Q

what anti-cancer drug can cause:

bladder cancer =
sterility/infertility =
nephrotoxicty and deafness =

A
cyclophosphamide;
alkylating agents (ie cyclophosphamide;

cisplatin

18
Q

the use of a ____ carrier with doxorubicine has reduced cardiac toxicity

A

liposomal

19
Q

sirolimus/rapamycin can cause what 2 metabolic toxicities?

A

insulin resistance;

hyperlipidemia

20
Q

hypertension is seen with drugs that inhibit _____

A

angiogenesis

21
Q

what is the main reason for anti-cancer treatment failure?

A

chemoresistance

22
Q

an increase in drug efflux is coded for by the _____ gene. this causes increased expression of _____

A

multi-drug resistance;

P-glycoprotein (a drug transport protein)

23
Q

combination chemotherapy regimens reduce both ____ and ______

A

tumor resistance;
toxicity

in theory

24
Q

_____ therapy is chronic, equally spaced low doses of drug without extended rest periods

A

metronomic

25
Q

______ is a new drug that targets cyclin dependent kinases

A

flavopiridol

also downregulates VEGF
causes neutropenia and diarrhea

26
Q

____ ____ is using drugs other than anticancer drugs to weaken pathways that enable cancer cells to survive

A

drug repositioning